Table 1 Characteristics of study participants

From: Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia

Characteristics

Probands

Participating family members

Participants

Carriers

Noncarriers

N

21

20

44

Age (years)

47.7 (15.9)

47.3 (17.5)

46.25 (17.11)

Women

9 (43%)

9 (45%)

22 (50%)

Blood pressure (mmHg)

 Systolic

132.4 (25.0)

135.2 (19.2)

137.6 (22.1)

 Diastolic

82. 9 (10.2)

84.8 (12.1)

84.5 (11.3)

LDL-C (mmol/L)

5.3 (2.1)

5.1 (1.8)

3.4 (0.9)

TC (mmol/L)

7.3 (2.2)

6.8 (1.9)

5.2 (0.9)

HDL-C (mmol/L)

1.9 (0.8)

1.6 (0.4)

1.7 (0.4)

TG (mmol/L)

1.2 (0.7)

1.4 (0.9)

1.1 (0.7)

Diabetes mellitus

0 (0%)

1 (5%)

3 (7%)

Hypercholesterolemia

13 (62%)

8 (40%)

3 (7%)

FH

3 (14%)

0 (0%)

0 (0%)

Prevalent ASCVD

2 (10%)

2 (10%)

6 (14%)

Body mass index

26.5 (9.2)

27.8 (5.7)

27.3 (5.3)

Current smokers

7 (33%)

4 (20%)

13 (30%)

Lipid-lowering medication prescription

13 (62%)

6 (30%)

8 (18%)

Lipid-lowering medication use

8 (38%)

5 (25%)

9 (20%)

Antihypertensive medication use

4 (19%)

6 (30%)

13 (30%)

  1. Data are number (%) or mean (SD).
  2. ASCVD atherosclerotic cardiovascular disease, FH familial hypercholesterolemia, HDL high-density lipoprotein, LDL low-density lipoprotein, TC total cholesterol, TG triglycerides.